PerkinElmer Inc. (NYSE:PKI) – KeyCorp decreased their Q4 2016 earnings per share (EPS) estimates for shares of PerkinElmer in a report released on Tuesday. KeyCorp analyst M. Mishan now anticipates that the brokerage will post earnings per share of $0.86 for the quarter, down from their previous forecast of $0.92.

PerkinElmer (NYSE:PKI) last posted its quarterly earnings data on Monday, November 7th. The company reported $0.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.02. The business earned $548 million during the quarter, compared to the consensus estimate of $572.03 million. PerkinElmer had a net margin of 10.48% and a return on equity of 14.55%. PerkinElmer’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.60 EPS.

Earnings History and Estimates for PerkinElmer (NYSE:PKI)

Other research analysts have also issued research reports about the stock. JPMorgan Chase & Co. lifted their price objective on shares of PerkinElmer from $52.00 to $55.00 and gave the stock a “neutral” rating in a research note on Friday, August 5th. Barclays PLC raised their target price on shares of PerkinElmer from $50.00 to $52.00 and gave the stock an “underweight” rating in a report on Friday, August 5th. BTIG Research restated a “hold” rating on shares of PerkinElmer in a report on Friday, August 5th. Mizuho downgraded shares of PerkinElmer from a “buy” rating to a “neutral” rating and set a $56.00 target price on the stock. in a report on Friday, August 5th. Finally, Jefferies Group raised their target price on shares of PerkinElmer from $52.00 to $55.00 and gave the stock a “hold” rating in a report on Friday, August 5th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $54.92.

Shares of PerkinElmer (NYSE:PKI) opened at 50.90 on Thursday. The company’s 50 day moving average is $53.00 and its 200 day moving average is $53.71. The company has a market capitalization of $5.57 billion, a P/E ratio of 24.32 and a beta of 0.94. PerkinElmer has a 12-month low of $39.50 and a 12-month high of $57.28.

A number of institutional investors have recently added to or reduced their stakes in the company. Toth Financial Advisory Corp boosted its position in PerkinElmer by 2.0% in the second quarter. Toth Financial Advisory Corp now owns 10,100 shares of the company’s stock worth $529,000 after buying an additional 200 shares during the period. Sector Gamma AS boosted its position in PerkinElmer by 22.7% in the first quarter. Sector Gamma AS now owns 499,030 shares of the company’s stock worth $24,682,000 after buying an additional 92,400 shares during the period. BlueMountain Capital Management LLC bought a new position in PerkinElmer during the first quarter worth approximately $561,000. Squarepoint Ops LLC bought a new position in PerkinElmer during the first quarter worth approximately $1,558,000. Finally, Seven Eight Capital LLC bought a new position in PerkinElmer during the first quarter worth approximately $489,000. 90.17% of the stock is owned by hedge funds and other institutional investors.

In other PerkinElmer news, insider Joel S. Goldberg sold 38,095 shares of PerkinElmer stock in a transaction on Thursday, September 22nd. The shares were sold at an average price of $55.00, for a total transaction of $2,095,225.00. Following the completion of the transaction, the insider now directly owns 96,299 shares of the company’s stock, valued at $5,296,445. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Daniel R. Tereau sold 18,866 shares of PerkinElmer stock in a transaction on Monday, September 12th. The stock was sold at an average price of $52.00, for a total transaction of $981,032.00. Following the transaction, the insider now directly owns 21,241 shares of the company’s stock, valued at $1,104,532. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company’s stock.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Friday, January 20th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Wednesday, January 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.55%. PerkinElmer’s payout ratio is 13.02%.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company’s operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier.

5 Day Chart for NYSE:PKI

Receive News & Stock Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related stocks with our FREE daily email newsletter.